Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:EDAP NYSE:NVRO NASDAQ:STIM NASDAQ:TCMD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEDAPEdap Tms$1.47+0.1%$1.77$1.26▼$5.27$55.04MN/A99,036 shs99,741 shsNVRONevro$5.85+0.1%$5.85$3.17▼$10.37$224.32M0.81805,231 shs753,602 shsSTIMNeuronetics$3.60-3.9%$3.80$0.52▼$5.92$237.68M1.85841,873 shs1.34 million shsTCMDTactile Systems Technology$9.81+1.5%$10.00$8.61▼$21.10$227.95M0.95250,601 shs130,695 shsA Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEDAPEdap Tms-2.33%-4.17%-14.04%+12.21%-70.30%NVRONevro0.00%0.00%0.00%0.00%-38.79%STIMNeuronetics-3.11%+9.36%-1.32%-0.80%+97.88%TCMDTactile Systems Technology-3.78%-3.21%-1.83%-27.64%-22.35%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEDAPEdap Tms3.0463 of 5 stars3.25.00.00.02.71.70.6NVRONevroN/AN/AN/AN/AN/AN/AN/AN/ASTIMNeuronetics1.788 of 5 stars3.31.00.00.01.91.70.6TCMDTactile Systems Technology3.6049 of 5 stars3.02.00.00.02.62.53.1Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEDAPEdap Tms 2.33Hold$8.50477.45% UpsideNVRONevro 1.92Reduce$5.36-8.29% DownsideSTIMNeuronetics 2.67Moderate Buy$5.5052.99% UpsideTCMDTactile Systems Technology 2.00Hold$16.0063.18% UpsideCurrent Analyst Ratings BreakdownLatest EDAP, TCMD, NVRO, and STIM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/15/2025EDAPEdap TmsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOverweight ➝ Neutral5/7/2025TCMDTactile Systems TechnologyB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold5/6/2025TCMDTactile Systems TechnologyPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOverweight ➝ Neutral$25.00 ➝ $14.00(Data available from 7/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEDAPEdap Tms$69.18M0.80N/AN/A$1.18 per share1.25NVRONevro$408.52M0.55N/AN/A$8.10 per share0.72STIMNeuronetics$89.45M2.66N/AN/A$0.57 per share6.31TCMDTactile Systems Technology$293.16M0.78$1.06 per share9.28$9.03 per share1.09Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEDAPEdap Tms-$20.58M-$0.62N/AN/AN/A-34.45%-51.42%-26.43%8/27/2025 (Estimated)NVRONevro-$92.21M-$3.05N/AN/AN/A-16.54%-23.52%-10.83%8/4/2025 (Estimated)STIMNeuronetics-$43.71M-$1.31N/AN/AN/A-53.67%-174.15%-38.41%8/11/2025 (Estimated)TCMDTactile Systems Technology$16.96M$0.6614.8611.67N/A5.52%8.41%6.10%8/4/2025 (Estimated)Latest EDAP, TCMD, NVRO, and STIM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/11/2025Q2 2025STIMNeuronetics-$0.08N/AN/AN/A$36.80 millionN/A8/4/2025Q2 2025TCMDTactile Systems Technology$0.09N/AN/AN/A$73.93 millionN/A5/15/2025Q1 2025EDAPEdap Tms-$0.16-$0.20-$0.04-$0.20$16.56 million$16.37 million5/6/2025Q1 2025STIMNeuronetics-$0.13-$0.21-$0.08-$0.21$29.07 million$31.98 million5/5/2025Q1 2025TCMDTactile Systems Technology-$0.07-$0.13-$0.06-$0.13$63.48 million$61.27 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEDAPEdap TmsN/AN/AN/AN/AN/ANVRONevroN/AN/AN/AN/AN/ASTIMNeuroneticsN/AN/AN/AN/AN/ATCMDTactile Systems TechnologyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEDAPEdap Tms0.101.741.21NVRONevro0.675.023.76STIMNeuronetics1.402.442.28TCMDTactile Systems Technology0.114.523.99Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEDAPEdap Tms62.74%NVRONevro95.52%STIMNeuronetics53.59%TCMDTactile Systems Technology83.43%Insider OwnershipCompanyInsider OwnershipEDAPEdap Tms0.23%NVRONevro3.20%STIMNeuronetics9.80%TCMDTactile Systems Technology2.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEDAPEdap Tms23037.39 million37.31 millionOptionableNVRONevro1,09038.37 million36.27 millionOptionableSTIMNeuronetics18066.11 million59.64 millionOptionableTCMDTactile Systems Technology1,03723.25 million22.67 millionOptionableEDAP, TCMD, NVRO, and STIM HeadlinesRecent News About These Companies3 Small Caps Drawing Insider and Institutional Support (TCMD)...July 14 at 7:23 AM | marketbeat.comTCMD Tactile Systems Technology, Inc. - Seeking AlphaJuly 2, 2025 | seekingalpha.comTactile Systems Technology (NASDAQ:TCMD) investors are sitting on a loss of 76% if they invested five years agoJune 23, 2025 | finance.yahoo.comNew Data Demonstrates Significant Clinical and Quality-of-Life Benefits of Flexitouch® Plus in Treating Lymphedema Among Head and Neck Cancer SurvivorsJune 3, 2025 | globenewswire.comTactile Medical to Present at Upcoming Investor Conferences in JuneMay 20, 2025 | globenewswire.comTactile Systems Technology, Inc. (NASDAQ:TCMD) CFO Sells $29,034.74 in StockMay 15, 2025 | insidertrades.comTactile Systems Technology's (NASDAQ:TCMD) Soft Earnings Don't Show The Whole PictureMay 13, 2025 | finance.yahoo.comTactile Systems Technology, Inc. (NASDAQ:TCMD) Director Sells $31,911.00 in StockMay 10, 2025 | insidertrades.comPiper Sandler Downgrades Tactile Systems Technology (TCMD)May 8, 2025 | msn.comAnalysts Have Been Trimming Their Tactile Systems Technology, Inc. (NASDAQ:TCMD) Price Target After Its Latest ReportMay 7, 2025 | finance.yahoo.comWhy Tactile Systems Technology, Inc.’s (TCMD) Stock Is Down 33.21%May 6, 2025 | aaii.comATactile Systems stock tumbles after Q1 missMay 6, 2025 | investing.comTactile Systems downgraded to Neutral from Overweight at Piper SandlerMay 6, 2025 | msn.comTactile Systems Technology, Inc. (TCMD) Q1 2025 Earnings Call TranscriptMay 5, 2025 | seekingalpha.comWith 81% institutional ownership, Tactile Systems Technology, Inc. (NASDAQ:TCMD) is a favorite amongst the big gunsMay 5, 2025 | uk.finance.yahoo.comTactile Systems Technology (TCMD) Reports Q1 Loss, Lags Revenue EstimatesMay 5, 2025 | zacks.comTactile Systems Technology, Inc. Reports First Quarter 2025 Financial ResultsMay 5, 2025 | globenewswire.comWhat To Expect From Tactile Systems Technology Inc (TCMD) Q1 2025 EarningsMay 3, 2025 | finance.yahoo.comTactile Medical to Release First Quarter of Fiscal Year 2025 Financial Results on May 5, 2025April 21, 2025 | globenewswire.comTactile Systems Technology: Interesting Devices Company, Need More ClarityApril 7, 2025 | seekingalpha.comThe Returns At Tactile Systems Technology (NASDAQ:TCMD) Aren't GrowingMarch 18, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeEDAP, TCMD, NVRO, and STIM Company DescriptionsEdap Tms NASDAQ:EDAP$1.48 +0.01 (+0.34%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.Nevro NYSE:NVRONevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems. It also offers Senza HFX iQ platform, that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system; and provides sacroiliac joint fusion devices under NevroV1, NevroFix, and NevroPro brands. In addition, the company offers surpass surgical and percutaneous leads. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California.Neuronetics NASDAQ:STIM$3.60 -0.15 (-3.88%) Closing price 03:59 PM EasternExtended Trading$3.60 0.00 (0.00%) As of 04:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.Tactile Systems Technology NASDAQ:TCMD$9.80 +0.15 (+1.50%) Closing price 03:59 PM EasternExtended Trading$9.80 0.00 (0.00%) As of 04:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AMD Just Triggered a Signal Traders Can’t Ignore This ASML Dip Could Be Gone Before You Know It—Don’t Miss Out Rocket Lab Gets New Street-High Price Target from Citi Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters 3 Analysts Set $600 Target Ahead of Microsoft Earnings Salesforce Stock Set for 30% Upside to Reach New Highs JPMorgan Q2 Results Affirm Dividend, Buybacks, & Growth NVDA Greenlight: China H20 Sales Spark 50% Rally Potential Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
